Skip to main content

Table 1 Details of rheumatoid arthritis (RA) and non-RA patients

From: Chemokine receptors in the rheumatoid synovium: upregulation of CXCR5

Patient (sex, age [years]) Diagnosis/pathology Disease duration (years) Medication
1 (male, 69) RA 37 Auranofin, NSAID
2 (female, 41) RA 23 NSAID
3 (female, 51) RA 10 NSAID, analgesic
4 (female, 79) RA 4 Methotrexate, NSAID, steroid
5 (female, 70) RA 8 Penicillamine, steroid, NSAID
6 (female, 63) RA + secondary osteoarthritis 39 Methotrexate, steroid, analgesic
7 (female, 33) juvenile chronic arthritis 20 NSAID
8 (female, 66) RA 38 NSAID, analgesic
1 (female, 50) Articular cartilage damage <1 NSAID, analgesic
2 (male, 44) Meniscal tear <1 -
3 (male, 42) Meniscal tear and articular cartilage damage 4 -
4 (male, 60) Meniscal degeneration <1 -
5 (male, 52) Articular cartilage degeneration 1 -
6 (male, 46) Meniscal tear <1 -
7 (male, 53) Meniscal degeneration <1 -
8 (male, 38) Meniscal tear 1 Steroid
9 (male, 43) Articular cartilage degeneration <1 -
1 (female, 91) RA <1 Analgesic
2 (female, 56) RA <1 NSAID, steroid, methotrexate
3 (male, 67) RA   -
4 (male, 67) RA 4 Analgesic, NSAID, methotrexate
  1. Synovia were obtained from eight RA patients and nine non-RA patients.
  2. Monocytes/macrophages from peripheral blood/synovial fluid were obtained from the last four patients. NSAID, non-steroidal anti-inflammatory drug.